National Health Investors (NHI) closed at $62.95 on November 13, 2026, down 2.5% from the previous close, on volume of 447,123 shares (30-day average 294,218).
Data as of November 13, 2026.
National Health Investors Adopts Director and Officer Indemnification Agreements
TipRanks (Fri, 13-Nov 5:30 PM ET)
National Health, Kite Realty, Alexandria Real Estate Equities downgraded at BofA after Q3 earnings
Seeking Alpha News (Fri, 13-Nov 8:06 AM ET)
NHI Earnings Call Highlights SHOP Growth and Guidance
TipRanks (Wed, 11-Nov 7:15 PM ET)
Wells Fargo Remains a Hold on National Health Investors (NHI)
TipRanks (Tue, 10-Nov 6:37 AM ET)
National Health Investors declares $0.94 dividend
Seeking Alpha News (Tue, 10-Nov 6:08 AM ET)
National Health Investors Issues Investor Update and Presentation
TipRanks (Mon, 9-Nov 5:38 PM ET)
National Health Investors Reports Third-Quarter Portfolio and Operating Information
TipRanks (Mon, 9-Nov 5:18 PM ET)
National Health Investors FFO of $1.12 misses by $0.02, revenue of $113.48M beats by $1.32M
Seeking Alpha News (Mon, 9-Nov 4:26 PM ET)
PRNewswire (Mon, 9-Nov 4:10 PM ET)
NHI Announces Third Quarter 2026 Results
PRNewswire (Mon, 9-Nov 4:05 PM ET)
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
National Health Investors trades on the NYSE stock market under the symbol NHI.
As of November 13, 2026, NHI stock price declined to $62.95 with 447,123 million shares trading.
NHI has a beta of -0.46, meaning it tends to be less sensitive to market movements. NHI has a correlation of 0.06 to the broad based SPY ETF.
NHI has a market cap of $3.09 billion. This is considered a Mid Cap stock.
Last quarter National Health Investors reported $113 million in Revenue and $1.12 earnings per share. This beat revenue expectation by $333,816 and missed earnings estimates by -$.05.
In the last 3 years, NHI traded as high as $91.38 and as low as $50.57.
The top ETF exchange traded funds that NHI belongs to (by Net Assets): IJR, VNQ, VTI, IWM, VB.
NHI has underperformed the market in the last year with a price return of -12.5% while the SPY ETF gained +11.5%. NHI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.7% and -6.0%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
NHI support price is $63.33 and resistance is $65.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NHI shares will trade within this expected range on the day.
